NCE Areas of Clinical Focus Questions

Negative psychotic symptoms representing a marked diminution or loss of normal psychological functions is correct because negative symptoms in schizophrenia account for a deficit, decrease, or restriction in normal cognitive, affective, and behavioral functioning. The primary negative symptoms recognized in the DSM-5-TR include blunted affect (diminished emotional expression), alogia (poverty of speech), avolition (inability to initiate and persist in goal-directed activities), asociality, and anhedonia. Positive psychotic symptoms reflecting an excess or distortion of normal psychological functioning is incorrect because positive symptoms represent an addition to or distortion of normal psychological processes, such as delusions, hallucinations, and grossly disorganized thinking or speech. Disorganized psychomotor symptoms reflecting acute behavioral agitation and purposeless motoric actions is incorrect because psychomotor agitation describes abnormal, excessive motor activity that is purposeless and non-attributable to external stimuli, rather than affective flattening or avolition. Catatonic neurological symptoms characterized by extreme rigidity, waxy flexibility, and involuntary posturing is incorrect because catatonia encompasses specific neuromotor syndromes involving stupor, catalepsy, mutism, negativism, posturing, and waxy flexibility rather than general avolitional or blunted affective presentations.

Female orgasmic disorder involves the presence of a marked delay in, marked infrequency of, or absence of orgasm, or markedly reduced intensity of orgasmic sensations, occurring on almost all or all occasions of sexual activity for at least six months and causing clinically significant distress. Female sexual interest or arousal disorder is incorrect because it involves a lack of or significantly reduced sexual interest, erotic thoughts, fantasies, or physiological arousal, whereas this client reports intact sexual desire and physiological arousal during intimacy. Genito-pelvic pain or penetration disorder is incorrect because it is defined by persistent difficulties concerning vaginal penetration, marked vulvovaginal or pelvic pain during intercourse, or marked fear and anxiety about pain, none of which are described. Hypoactive sexual desire disorder is incorrect because in the DSM-5, desire disorders in females are conceptualized under female sexual interest or arousal disorder, and regardless, this client actively experiences adequate sexual desire and initiates partnered encounters.

Paranoid personality disorder is defined in the DSM-5 by a pervasive distrust and suspiciousness of others such that their motives are interpreted as malevolent, beginning by early adulthood. Clients with this disorder suspect without sufficient basis that others are exploiting, harming, or deceiving them, bear persistent grudges, and read hidden threatening meanings into benign remarks or events. In contrast, schizotypal personality disorder involves pervasive social and interpersonal deficits characterized by acute discomfort in close relationships, cognitive or perceptual distortions, and eccentricities of behavior, rather than purely suspicious interpretative frameworks. Avoidant personality disorder involves social inhibition, feelings of inadequacy, and extreme hypersensitivity to negative evaluation; these individuals desire social connection but avoid interactions out of fear of rejection or humiliation, whereas paranoid individuals avoid closeness due to profound distrust of others' intentions. Borderline personality disorder is characterized by a pervasive pattern of instability in interpersonal relationships, self-image, and affects, along with marked impulsivity and frantic efforts to avoid real or imagined abandonment, rather than a primary, pervasive worldview centered on malicious external motives.

An abrupt surge of intense fear reaching a peak within minutes with four or more symptoms is correct because the DSM-5-TR explicitly defines a panic attack as an abrupt surge of intense fear or intense discomfort that reaches a peak within minutes, during which time four (or more) of thirteen listed physical and cognitive symptoms (such as palpitations, sweating, trembling, dyspnea, and fear of dying) occur. A gradual buildup of generalized anxiety reaching peak intensity over several hours with two symptoms is incorrect because this gradual temporal pattern describes generalized anxiety or chronic stress, failing both the acute minutes-to-peak requirement and the four-symptom minimum threshold. A persistent state of autonomic hyperarousal lasting at least one full day with three somatic symptoms is incorrect because sustained autonomic arousal over 24 hours does not reflect the episodic, acute nature of a panic attack and aligns more closely with generalized anxiety criteria. An episodic fear response triggered solely by specific phobic stimuli accompanied by two physiological symptoms is incorrect because panic attacks can occur unexpectedly or expectedly and require at least four symptoms to meet diagnostic criteria.

A formal diagnosis of antisocial personality disorder requires that the individual be at least 18 years of age and have a documented history of conduct disorder before the age of 15. Even when a 17-year-old client exhibits severe violations of social norms, aggression, deceitfulness, and lack of remorse, diagnostic criteria prohibit diagnosing antisocial personality disorder before the age of 18. Instead, conduct disorder is the proper classification during late adolescence. Lacking documented proof of persistent substance abuse does not preclude the diagnosis, as substance use is a common co-occurring issue rather than a required diagnostic criterion. Symptoms being better explained by oppositional defiant disorder is inaccurate because chronic aggression and violation of personal rights far exceed the oppositional threshold and define conduct disorder. Requiring a completed mandatory forensic court assessment is incorrect because psychiatric diagnosis relies on clinical criteria rather than judicial mandates.

Under the DSM-5-TR, a formal diagnosis of schizophrenia requires two or more Criterion A symptoms, including at least one core feature such as delusions, hallucinations, or disorganized speech, present for a significant portion of time during a one-month period or less if successfully treated. Additionally, continuous signs of the disturbance must persist for at least six months, which may include prodromal or residual periods of attenuated symptoms. The option specifying active symptoms for two weeks and overall disturbance for three months aligns more closely with brief psychotic disorder or schizophreniform disorder timelines rather than schizophrenia. The option listing active symptoms for three months and overall disturbance for one year exceeds the baseline minimum duration required by diagnostic standards. The option proposing active symptoms for six months with continuous disturbance for two years confuses the diagnostic timeline of schizophrenia with persistent depressive disorder or cyclothymic chronicity thresholds.

Disulfiram serves as an aversive pharmacological agent utilized in the treatment of chronic alcohol use disorder. It functions by irreversibly inhibiting the hepatic enzyme aldehyde dehydrogenase, which normally metabolizes acetaldehyde into acetic acid. When a client taking disulfiram consumes alcohol, acetaldehyde accumulates rapidly in the bloodstream to toxic levels, precipitating an unpleasant physical reaction characterized by facial flushing, throbbing headache, nausea, vomiting, chest tightness, palpitations, and hypotension. Stimulating central dopamine release to decrease psychological cravings for alcohol is incorrect because disulfiram is not an anti-craving medication; it deters drinking through the aversive reaction, while naltrexone and acamprosate are the medications used to reduce craving. Blocking mu-opioid receptors to reduce the pleasurable reinforcement of alcohol is incorrect because this mechanism describes naltrexone, an opioid antagonist that attenuates the rewarding effects of drinking. Enhancing GABA transmission to suppress withdrawal seizures during early detoxification is incorrect because this describes the action of benzodiazepines utilized in acute alcohol detoxification rather than an aversive maintenance medication like disulfiram.